J Genet Eng Biotechnol, 2023, 21(1):23

Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines

The biopharmaceutical industry is significantly growing worldwide, and the Chinese hamster ovary (CHO) cells are used as a main expression host for the production of recombinant monoclonal antibodies. Various metabolic engineering approaches have been investigated to generate cell lines with improved metabolic characteristics for increasing longevity and mAb production. A novel cell culture method based on the 2-stage selection makes it possible to develop a stable cell line with high-quality mAb production.

Toporova VA, Argentova VV, Aliev TK, Panina AA, Dolgikh DA, Kirpichnikov MP

Bioengineering department, Laboratory of protein engineering

: 10.1186/s43141-023-00474-0
Scopus: 2-s2.0-85148744354
: 36811683
IBCH: 10586
Ссылка на статью в журнале: https://jgeb.springeropen.com/articles/10.1186/s43141-023-00474-0
Нет данных о цитировании
Данные статьи проверены модераторами 2023-03-13

Список научных проектов, где отмечена публикация

  1. Development of means of prevention and treatment of COVID-19 and concomitant infectious diseases using genetic technologies (September 28, 2021 — December 31, 2023). Gabibov A.G., Andreev D.E., Aralov A.V., Bezuglov V.V., Belogurov A.A., Vodovozova E.L., Zvyagin A.V., Konstantinova I.D., Korshun V.A., Ovchinnikova T.V., Rubcov Y.P., Smirnov I.V., Tonevickiy A.G.. Agreement / contract, Ministry of Science.